Search for: "Amgen"
Regenicin Appoints Amgen Co-founder Dr. Joseph Rubinfeld to Board of Directors
HSMN NewsFeed,
24 Aug 2010:
Regenerative Medicine, Personnel
[Regenicin, skin substitute]
|
ImmunoGen, Inc. Announces Orphan Drug Designation Granted to Lorvotuzumab Mertansine for Treatment of Small-Cell Lung Cancer
HSMN NewsFeed,
18 Aug 2010:
Biopharmaceuticals, Oncology, FDA
[ImmunoGen, lorvotuzumab mertansine, lung cancer]
|
Human Genome Sciences Names Tuomo Pätsi Vice President, HGS Europe
HSMN NewsFeed,
13 Aug 2010:
Biopharmaceuticals, Personnel
[Human Genome Sciences]
|
Dicerna Closes $25 Million Series B Financing
HSMN NewsFeed,
11 Aug 2010:
Biopharmaceuticals, Venture Capital, Personnel
[Dicerna Pharmaceuticals]
|
TetraLogic Pharmaceuticals Completes $32 Million Series C Financing
HSMN NewsFeed,
10 Aug 2010:
Biopharmaceuticals, Venture Capital, Personnel
[TetraLogic Pharmaceuticals]
|
Amgen Appoints Jonathan M. Peacock Executive Vice President and Chief Financial Officer
HSMN NewsFeed,
15 Jul 2010:
Biopharmaceuticals, Personnel
[Amgen]
|
K-V Pharmaceutical Company Announces the Election of New Independent Member to Board of Directors
HSMN NewsFeed,
7 Jul 2010:
Biopharmaceuticals, Personnel
[K-V Pharmaceutical]
|
AlloCure Names Robert M. Brenner, M.D. Chief Executive Officer
HSMN NewsFeed,
6 Jul 2010:
Regenerative Medicine, Personnel
[AlloCure, NephroGen]
|
BioVex Appoints Steven Kelly as Chief Commercial Officer
HSMN NewsFeed,
1 Jul 2010:
Biopharmaceuticals, Personnel
[BioVex, OncoVEX]
|
Calistoga Pharmaceuticals Raises $40 Million in Series C Financing
HSMN NewsFeed,
30 Jun 2010:
Biopharmaceuticals, Venture Capital
[Calistoga Pharmaceuticals, phosphatidylinositol 3 kinase]
|
Vertos Medical Expands Executive Team Amidst Growing Commercial Acceptance of mild(R)
HSMN NewsFeed,
18 Jun 2010:
Devices, Orthopaedic, Neurosurgery, Personnel
[Vertos Medical, lumbar spinal stenosis]
|
Relypsa Appoints Claire J. Lockey Vice President, Regulatory Affairs
HSMN NewsFeed,
16 Jun 2010:
Biopharmaceuticals, Personnel
[Relypsa]
|
FDA Approves Amgen's Prolia(TM) (Denosumab) for Treatment of Postmenopausal Women With Osteoporosis at High Risk for Fracture
HSMN NewsFeed,
1 Jun 2010:
Biopharmaceuticals, FDA
[Amgen, Prolia, denosumab, osteoporosis]
|
Prolia(R) (Denosumab) Granted Marketing Authorization in the European Union
HSMN NewsFeed,
28 May 2010:
Biopharmaceuticals, Regulatory
[Amgen, Prolia, denosumab, osteoporosis]
|
Allostera Pharma Inc. Appoints Christopher Henney as Chairman of its Board of Directors
HSMN NewsFeed,
19 May 2010:
Biopharmaceuticals, Personnel
[Allostera Pharma, Allosteramers]
|
Teva Announces Tentative Approval of Generic Sensipar(R)
HSMN NewsFeed,
14 May 2010:
Biopharmaceuticals, Generics, FDA
[Teva Pharmaceutical, Cinacalcet, Amgen, Sensipar]
|
Amgen Appoints Robert A. Bradway President and Chief Operating Officer
HSMN NewsFeed,
26 Apr 2010:
Biopharmaceuticals, Personnel
[Amgen]
|
Satori Pharmaceuticals Adds Key Senior Members to its Leadership Team
HSMN NewsFeed,
26 Apr 2010:
Biopharmaceuticals, Personnel
[Satori Pharmaceuticals]
|
Mirina Corporation Closes Series A-1 Financing Led by Versant Ventures
HSMN NewsFeed,
26 Apr 2010:
Biopharmaceuticals, Venture Capital
[Mirina Corporation]
|
Epizyme Expands Leadership Team, Appointing Robert Gould, Ph.D. as CEO and Jason Rhodes as EVP and CBO
HSMN NewsFeed,
24 Mar 2010:
Biopharmaceuticals, Personnel
[Epizyme]
|
Cytokinetics Announces Orphan Drug Designation Granted to CK-2017357 for the Treatment of Amyotrophic Lateral Sclerosis
HSMN NewsFeed,
10 Mar 2010:
Biopharmaceuticals, Neurology, FDA
[Cytokinetics, CK-2017357, amyotrophic lateral sclerosis]
|
Stephen Hitchcock to Head Drug Discovery at Envoy Therapeutics
HSMN NewsFeed,
1 Mar 2010:
Biopharmaceuticals, Personnel
[Envoy Therapeutics, bacTRAP]
|
FDA Classifies Prolia(TM) (Denosumab) Complete Response Submission and Targets Action Date
HSMN NewsFeed,
19 Feb 2010:
Biopharmaceuticals, FDA
[Amgen, Prolia, denosumab, osteoporosis]
|
TOPICA Names Mark W. Davis Vice President of Clinical Development
HSMN NewsFeed,
18 Feb 2010:
Biopharmaceuticals, Personnel
[TOPICA Pharmaceuticals]
|
Centocor Ortho Biotech Products and Amgen Finalize ESA Risk Evaluation and Mitigation Strategy (REMS) With FDA
HSMN NewsFeed,
16 Feb 2010:
Biopharmaceuticals, Oncology, FDA
[Centocor Ortho Biotech, Amgen, erythropoiesis, EPOGEN, Aranesp, Procrit]
|
Elbit Imaging Announces Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma
HSMN NewsFeed,
10 Feb 2010:
Regenerative Medicine, Oncology
[Elbit Imaging, Gamida Cell, StemEx, ExCell, stem cell]
|
Denosumab Demonstrated Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Prostate Cancer Patients With Bone Metastases
HSMN NewsFeed,
8 Feb 2010:
Biopharmaceuticals, Oncology
[Amgen, denosumab, Zometa, zoledronic, bone metastases]
|
Neuraltus Pharmaceuticals Names Andrew Gengos President and CEO
HSMN NewsFeed,
8 Feb 2010:
Biopharmaceuticals, Personnel
[Neuraltus Pharmaceuticals]
|
Amgen Presents Complete Results From Two Pivotal Phase 3 Studies of Vectibix(R) at Gastrointestinal Cancers Symposium
HSMN NewsFeed,
21 Jan 2010:
Biopharmaceuticals, Oncology
[Amgen, Vectibix, panitumumab, colorectal cancer]
|
The Foundry Announces Completion of Series A Financing for Twelfth Company
HSMN NewsFeed,
13 Jan 2010:
Devices, Venture Capital
[The Foundry]
|
Acceleron Pharma Expands Management Team with Two New Appointments
HSMN NewsFeed,
22 Dec 2009:
Biopharmaceuticals, Personnel
[Acceleron Pharma]
|
AMAG Pharmaceuticals, Inc. Announces Appointment of Lesley Russell to Board of Directors
HSMN NewsFeed,
17 Dec 2009:
Biopharmaceuticals, Personnel
[AMAG Pharmaceuticals, Feraheme, ferumoxytol]
|
ImmunoGen, Inc. Appoints Suzanne Cadden as Vice President, Regulatory Affairs & Quality
HSMN NewsFeed,
17 Dec 2009:
Biopharmaceuticals, Oncology, Personnel
[ImmunoGen]
|
Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs
HSMN NewsFeed,
17 Dec 2009:
Biopharmaceuticals, Personnel
[Protalix BioTherapeutics]
|
Dennis Winger Joins Nektar Therapeutics' Board of Directors
HSMN NewsFeed,
14 Dec 2009:
Biopharmaceuticals, Personnel
[Nektar Therapeutics]
|
Data Presented at San Antonio Breast Cancer Symposium Demonstrate Treatment with Denosumab is Superior to the Standard of Care
HSMN NewsFeed,
10 Dec 2009:
Biopharmaceuticals, Oncology
[Amgen, denosumab, Zometa, zoledronic acid]
|
Oxford BioTherapeutics Appoints Michael Moore as Chairman
HSMN NewsFeed,
9 Dec 2009:
Biopharmaceuticals, Personnel
[Oxford BioTherapeutics]
|
Epizyme Closes $40M Series B Financing
HSMN NewsFeed,
8 Dec 2009:
Biopharmaceuticals, Venture Capital
[Epizyme]
|
Four Senior Executives Join Orexigen(R) Therapeutics Management Team
HSMN NewsFeed,
23 Nov 2009:
Biopharmaceuticals, Personnel
[Orexigen Therapeutics]
|
Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer
HSMN NewsFeed,
5 Nov 2009:
Biopharmaceuticals, Oncology
[Amgen, Vectibix, panitumumab, metastatic colorectal cancer]
|
InterMune Announces Appointments of Senior Leadership to Prepare for Potential Launch of Pirfenidone
HSMN NewsFeed,
5 Nov 2009:
Biopharmaceuticals, Personnel
[InterMune, pirfenidone]
|
Amgen Provides Update on Status of Prolia(TM) (Denosumab) Biologics License Application (BLA) Submitted to the U.S. Food and Drug Administration (FDA)
HSMN NewsFeed,
19 Oct 2009:
Biopharmaceuticals, FDA
[Amgen, Prolia, denosumab, osteoporosis]
|
Epizyme Closes $32 Million Series B Financing, Led by New Investor Bay City Capital
HSMN NewsFeed,
7 Oct 2009:
Biopharmaceuticals, Venture Capital
[Epizyme, epigenetics]
|
Oncothyreon announces appointment of Douglas E. Williams, Ph.D., to board of directors
HSMN NewsFeed,
5 Oct 2009:
Biopharmaceuticals, Oncology, Personnel
[Oncothyreon]
|
Vectibix(R) in Combination With Chemotherapy Significantly Improves Progression-Free Survival in First-Line Metastatic Colorectal Cancer
HSMN NewsFeed,
24 Sep 2009:
Biopharmaceuticals, Oncology
[Amgen, Vectibix, panitumumab, colorectal cancer]
|
BurnsAdler Partners With Three Rivers Pharmaceuticals to Commercialize Infergen(R) in Brazil and Chile
HSMN NewsFeed,
23 Sep 2009:
Biopharmaceuticals, Licensing
[BurnsAdler Pharmaceuticals, Three Rivers Pharmaceuticals, Infergen]
|
Denosumab Demonstrates Superiority Over Zometa(R) in Delay of Complications Due to Bone Metastases in Advanced Breast Cancer Patients
HSMN NewsFeed,
22 Sep 2009:
Biopharmaceuticals, Oncology
[Amgen, denosumab, breast cancer]
|
Vectibix(R) in Combination With Chemotherapy Significantly Improves Progression-Free Survival in Second-Line Metastatic Colorectal Cancer
HSMN NewsFeed,
22 Sep 2009:
Biopharmaceuticals, Oncology
[Amgen, Vectibix, panitumumab, metastatic colorectal cancer]
|
Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases
HSMN NewsFeed,
21 Sep 2009:
Biopharmaceuticals, Oncology
[Amgen, denosumab, bone metastases]
|
Ironwood Appoints Thomas McCourt As Chief Commercial Officer and Senior Vice President of Marketing and Sales
HSMN NewsFeed,
14 Sep 2009:
Biopharmaceuticals, Personnel
[Ironwood Pharmaceuticals]
|
GENova names Dr. John Savin as Vice President
HSMN NewsFeed,
4 Sep 2009:
Biopharmaceuticals, Oncology, Personnel
[GENova Biotherapeutics]
|
XenoPort Appoints Dennis Fenton to Board
HSMN NewsFeed,
13 Aug 2009:
Biopharmaceuticals, Personnel
[XenoPort, Astellas Pharma, GlaxoSmithKline]
|
Alder Biopharmaceuticals Appoints Dr. Mark D. Young Senior VP Pharmaceutical Operations
HSMN NewsFeed,
12 Aug 2009:
Biopharmaceuticals, Personnel
[Alder Biopharmaceuticals]
|
Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis (PMO)
HSMN NewsFeed,
27 Jul 2009:
Biopharmaceuticals
[Amgen, GlaxoSmithKline, denosumab, postmenopausal osteoporosis]
|
Halozyme Therapeutics Appoints Jonathan Leff, M.D. as Vice President, Chief Medical Officer
HSMN NewsFeed,
27 Jul 2009:
Biopharmaceuticals, Personnel
[Halozyme Therapeutics]
|
Nuon Therapeutics Appoints Paulette Dillon, Chief Business Officer, and Tito Serafini, Chief Scientific Officer
HSMN NewsFeed,
16 Jul 2009:
Biopharmaceuticals, Personnel
[Nuon Therapeutics]
|
Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Chief Medical Officer
HSMN NewsFeed,
9 Jun 2009:
Biopharmaceuticals, Personnel
[Nektar Therapeutics]
|
miRagen Therapeutics, Inc. Accomplishes Funding Milestones and Secures Series A Extension
HSMN NewsFeed,
2 Jun 2009:
Biopharmaceuticals, Venture Capital
[miRagen Therapeutics]
|
Celldex Therapeutics, Inc. Enhances Precision Targeted Immunotherapy Platform with the Acquisition of CuraGen Corporation
HSMN NewsFeed,
29 May 2009:
Biopharmaceuticals, Mergers & Acquisitions
[Celldex Therapeutics, CuraGen]
|
Calistoga Pharmaceuticals Raises $30 Million in Series B Financing
HSMN NewsFeed,
5 May 2009:
Biopharmaceuticals, Venture Capital
[Calistoga Pharmaceuticals]
|
Zafgen, Inc. Appoints Matthias Jaffe to Chief Financial Officer and Vice President of Business Development
HSMN NewsFeed,
5 May 2009:
Biopharmaceuticals, Personnel
[Zafgen]
|
Lilly Names Susan Mahony Senior Vice President of Human Resources
HSMN NewsFeed,
17 Apr 2009:
Biopharmaceuticals, Personnel
[Eli Lilly]
|
EPIX Pharmaceuticals Announces Sale of U.S., Canadian and Australian Rights for MS-325 (formerly marketed as Vasovist, gadofosveset trisodium, by Bayer Schering Pharma) to Lantheus Medical Imaging, Inc.
HSMN NewsFeed,
7 Apr 2009:
Biopharmaceuticals, Radiology, Acquisitions
[EPIX Pharmaceuticals, Lantheus Medical Imaging, Vasovist, gadofosveset]
|
EPIX Pharmaceuticals Appoints Elkan Gamzu, Ph.D., as Permanent CEO
HSMN NewsFeed,
5 Mar 2009:
Biopharmaceuticals, Personnel
[EPIX Pharmaceuticals]
|
EPIX Pharmaceuticals Announces Resignation of Chief Business Officer
HSMN NewsFeed,
27 Feb 2009:
Biopharmaceuticals, Personnel
[EPIX Pharmaceuticals]
|
ARCA biopharma Appoints Kathryn Falberg as Chief Financial Officer and Chief Operating Officer
HSMN NewsFeed,
25 Feb 2009:
Biopharmaceuticals, Personnel
[ARCA biopharma]
|
Arcxis Biotechnologies(R) Secures Series B Financing
HSMN NewsFeed,
30 Jan 2009:
Diagnostics, Venture Capital
[Arcxis Biotechnologies]
|
NovaBay (NBY) Appoints Harry F. Hixson, Jr., PhD, Former Amgen President/Chief Operating Officer to Its Board of Directors
HSMN NewsFeed,
20 Jan 2009:
Biopharmaceuticals, Personnel
[NovaBay Pharmaceuticals]
|
Hana Biosciences Appoints Thomas J. Tarlow as Vice President, Regulatory Affairs and Quality
HSMN NewsFeed,
12 Jan 2009:
Biopharmaceuticals, Personnel
[Hana Biosciences]
|
EPIX Pharmaceuticals Announces FDA Approval of Vasovist(R) (gadofosveset trisodium)
HSMN NewsFeed,
22 Dec 2008:
Biopharmaceuticals, Radiology
[EPIX Pharmaceuticals, Vasovist, gadofosveset trisodium, MRA agent]
|
Amgen Submits Biologics License Application for FDA Approval of Denosumab in Women With Postmenopausal Osteoporosis and in Patients Undergoing Hormone Ablation for Either Prostate or Breast Cancer
HSMN NewsFeed,
19 Dec 2008:
Biopharmaceuticals
[Amgen, denosumab, osteoporosis, RANK Ligand]
|
NCCN Updates Guidelines for Colorectal Cancer
HSMN NewsFeed,
3 Nov 2008:
Biopharmaceuticals, Oncology
[National Comprehensive Cancer Network, KRAS, mCRC]
|
Enbrel(R) (etanercept) Is the First Biologic With Published Efficacy and Safety Data for up to a Decade of Continuous Use for the Treatment of Moderate to Severe Rheumatoid Arthritis
HSMN NewsFeed,
27 Oct 2008:
Biopharmaceuticals
[Amgen, ENBREL, rheumatoid arthritis]
|
EPIX Pharmaceuticals Announces Reduction in Force
HSMN NewsFeed,
23 Oct 2008:
Biopharmaceuticals
[EPIX Pharmaceuticals]
|
Surface Logix Appoints Keith Dionne as President and Chief Executive Officer
HSMN NewsFeed,
14 Oct 2008:
Biopharmaceuticals, Personnel
[Surface Logix]
|
One Year of GATTEX(TM) Therapy Safely Reduces Parenteral Nutrition Dependence for Patients with Short Bowel Syndrome
HSMN NewsFeed,
8 Oct 2008:
Biopharmaceuticals, Gastroenterology
[NPS Pharmaceuticals, GATTEX, teduglutide, short bowel syndrome]
|
Calistoga Pharmaceuticals Appoints Carol G. Gallagher, Pharm. D., Chief Executive Officer
HSMN NewsFeed,
8 Oct 2008:
Biopharmaceuticals, Personnel
[Calistoga Pharmaceuticals]
|
CytRx Corporation Completes Acquisition of Innovive Pharmaceuticals, Inc.
HSMN NewsFeed,
22 Sep 2008:
Biopharmaceuticals, Mergers & Acquisitions
[CytRx, Innovive Pharmaceuticals]
|
ARIAD Announces Court Rulings Regarding NF-(kappa)B Patent Lawsuit with Amgen
HSMN NewsFeed,
22 Sep 2008:
Biopharmaceuticals, Litigation
[ARIAD Pharmaceuticals, Amgen, Enbrel, etanercept]
|
Findings From Landmark Study Show Ustekinumab Demonstrated Superior Efficacy to Enbrel(R) (Etanercept) in Treatment of Moderate to Severe Plaque Psoriasis
HSMN NewsFeed,
18 Sep 2008:
Biopharmaceuticals, Dermatology
[Centocor, ustekinumab, etanercept, Enbrel, Psoriasis]
|
Memory Pharmaceuticals Realigns Workforce to Support Development Programs
HSMN NewsFeed,
17 Sep 2008:
Biopharmaceuticals
[Memory Pharmaceuticals]
|
Three Rivers Pharmaceuticals(R), LLC Obtains Additional Commercial Rights to Infergen(R) from Amgen Inc.
HSMN NewsFeed,
17 Sep 2008:
Biopharmaceuticals, Licensing
[Three Rivers Pharmaceuticals, Amgen, Infergen, hepatitis C]
|
Cytokinetics Announces Strategic Realignment of Workforce and Operations
HSMN NewsFeed,
16 Sep 2008:
Biopharmaceuticals
[Cytokinetics]
|
Denosumab Osteoporosis Trial Finds Patients Transitioned from Alendronate (Fosamax(R)) to Denosumab Achieved Significantly Greater Gains in Bone Mineral Density versus Those Continuing on Alendronate
HSMN NewsFeed,
15 Sep 2008:
Biopharmaceuticals
[Amgen, alendronate, Fosamax, denosumab, osteoporosis]
|
Biovitrum to Acquire Kepivance(R) and Stemgen(R) and Exclusively License Kineret(R) from Amgen
HSMN NewsFeed,
15 Sep 2008:
Biopharmaceuticals, Acquisitions, Licensing
[Biovitrum AB, Amgen, Kepivance, palifermin, Stemgen, ancestim, Kineret, anakinra]
|
Amgen and Wyeth Statement on the FDA Safety Announcement Regarding Tumor Necrosis Factor (TNF) Blockers
HSMN NewsFeed,
4 Sep 2008:
Biopharmaceuticals
[Amgen, Wyeth, Tumor Necrosis Factor, Remicade, Enbrel, Humira, Cimzia]
|
EPIX Pharmaceuticals To Regain Full Worldwide Commercial Rights For Vasovist(R)
HSMN NewsFeed,
4 Sep 2008:
Biopharmaceuticals, Radiology
[EPIX Pharmaceuticals, Bayer Schering Pharma, Vasovist, gadofosveset trisodium]
|
Osprey Pharmaceuticals U.S.A., Inc. Completes $11 Million Initial Private Financing
HSMN NewsFeed,
3 Sep 2008:
Biopharmaceuticals, Venture Capital
[Osprey Pharmaceuticals]
|
Monoclonal Antibody Sales to Almost Double in Coming Years
HSMN NewsFeed,
30 Aug 2008:
Biopharmaceuticals
[Monoclonal Antibody]
|
ARYx Therapeutics Appoints Amgen Executive to Board of Directors
HSMN NewsFeed,
29 Aug 2008:
Biopharmaceuticals, Personnel
[ARYx Therapeutics]
|
Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial
HSMN NewsFeed,
25 Aug 2008:
Biopharmaceuticals, Cardiology
[Anthera Pharmaceuticals, varespladib, Acute Coronary Syndrome, FRANCIS trial]
|
FDA Approves Nplate(TM) for Long-Term Treatment of Adult Chronic ITP
HSMN NewsFeed,
22 Aug 2008:
Biopharmaceuticals, FDA
[Amgen, Nplate, romiplostim]
|
Omeros Appoints David A. Mann to its Board of Directors
HSMN NewsFeed,
13 Aug 2008:
Biopharmaceuticals, Personnel
[Omeros Corp]
|
Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman
HSMN NewsFeed,
13 Aug 2008:
Biopharmaceuticals, Personnel, Venture Capital
[Anthera Pharmaceuticals]
|
Barr Confirms Patent Challenge of Sensipar(R) Tablets, 30mg, 60mg and 90mg
HSMN NewsFeed,
29 Jul 2008:
Biopharmaceuticals, Generics, FDA
[Barr Pharmaceuticals, Amgen, Sensipar, cincalcet]
|
Jim Miller, Ph.D. Joins Insmed Therapeutic Proteins as Vice President of Process Development
HSMN NewsFeed,
28 Jul 2008:
Biopharmaceuticals, Personnel
[Insmed]
|
EPIX Pharmaceuticals Announces Resignation of CEO; Names Elkan Gamzu Interim CEO
HSMN NewsFeed,
28 Jul 2008:
Biopharmaceuticals, Personnel
[EPIX Pharmaceuticals]
|
Amgen Announces Positive Top-Line Results for Denosumab Pivotal Postmenopausal Osteoporosis Trial
HSMN NewsFeed,
25 Jul 2008:
Biopharmaceuticals
[Amgen, denosumab, osteoporosis]
|
Amgen Announces Positive Top-Line Results for Denosumab Treatment of Bone Loss in Men With Non-Metastatic Prostate Cancer Undergoing Androgen Deprivation Therapy
HSMN NewsFeed,
14 Jul 2008:
Biopharmaceuticals, Oncology
[Amgen, denosumab, prostate cancer]
|
Amgen and Ortho Biotech Settle Antitrust Suit
HSMN NewsFeed,
11 Jul 2008:
Biopharmaceuticals, Oncology, Litigation
[Amgen, Ortho Biotech, Johnson & Johnson, Neupogen, Aranesp]
|
Poniard Pharmaceuticals Appoints Janet R. Rea to Vice President, Regulatory Affairs and Quality
HSMN NewsFeed,
10 Jul 2008:
Biopharmaceuticals, Regulatory
[Poniard Pharmaceuticals]
|
EPIX Pharmaceuticals Announces South Korean Approval of Vasovist(R); Novel Contrast Agent Now Approved for Marketing in 34 Countries
HSMN NewsFeed,
10 Jul 2008:
Biopharmaceuticals, Radiology, Regulatory
[EPIX Pharmaceuticals, Vasovist, gadofosveset trisodium]
|
Royalty Pharma Announces that James Reddoch, Ph.D., Joins Management Team
HSMN NewsFeed,
8 Jul 2008:
Biopharmaceuticals, Personnel
[Royalty Pharma]
|
EPIX Pharmaceuticals Announces Resubmission of New Drug Application for Vasovist(R)
HSMN NewsFeed,
1 Jul 2008:
Biopharmaceuticals
[EPIX Pharmaceuticals, Vasovist, gadofosveset, magnetic resonance angiography]
|
Clarient Launches New Colorectal Cancer Test
HSMN NewsFeed,
1 Jul 2008:
Diagnostics, Oncology
[Clarient, KRAS , colorectal cancer]
|
Akesis Pharmaceuticals Names Carl LeBel as President and Chief Operating Officer
HSMN NewsFeed,
30 Jun 2008:
Biopharmaceuticals, Personnel
[Akesis Pharmaceuticals]
|
Amgen and Wyeth Statement on Outcome of Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) Meeting
HSMN NewsFeed,
18 Jun 2008:
Biopharmaceuticals, Dermatology
[Amgen, Wyeth Pharmaceuticals, ENBREL, psoriasis]
|
William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals
HSMN NewsFeed,
18 Jun 2008:
Biopharmaceuticals, Personnel
[BioCryst Pharmaceuticals]
|
EntreMed Appoints Thomas H. Bliss as Senior Vice President of Corporate and Business Development
HSMN NewsFeed,
18 Jun 2008:
Biopharmaceuticals, Personnel
[EntreMed]
|
CytRx Corporation Signs Definitive Agreement to Acquire Innovive Pharmaceuticals, Inc.
HSMN NewsFeed,
9 Jun 2008:
Biopharmaceuticals, Mergers & Acquisitions
[CytRx, Innovive Pharmaceuticals]
|
Amgen and Wyeth Statement on the FDA Early Communication About Tumor Necrosis Factor (TNF) Blockers
HSMN NewsFeed,
4 Jun 2008:
Biopharmaceuticals
[Amgen, Wyeth Pharmaceuticals, Wyeth, Tumor Necrosis Factor]
|
Updated Data from Ongoing Phase 3 Trials Support the Continued Study of Vectibix(R) (panitumumab) in Combination with Standard Chemotherapy
HSMN NewsFeed,
1 Jun 2008:
Biopharmaceuticals, Oncology
[Amgen, Vectibix, panitumumab, colorectal cancer]
|
Amgen Reports Positive Data at ASCO from Three Studies of Denosumab in Cancer Patients
HSMN NewsFeed,
31 May 2008:
Biopharmaceuticals, Oncology
[Amgen, denosumab, Bone Mineral Density]
|
Interim Phase 2 Results of Open-Label Clinical Trial of Denosumab in Giant Cell Tumor of Bone Demonstrated 87 Percent Response Rate
HSMN NewsFeed,
31 May 2008:
Biopharmaceuticals, Oncology
[Amgen, denosumab, Giant Cell Tumor]
|
Amgen Presents New Data at ASCO on Four Investigational Molecules from Oncology Pipeline
HSMN NewsFeed,
31 May 2008:
Biopharmaceuticals, Oncology
[Amgen, Apo2L/TRAIL, AMG 479, AMG 102, motesanib]
|
Denosumab Achieved Superior Bone Mineral Density Gains in Head-to-Head Trial versus Weekly Alendronate (FOSAMAX(R))
HSMN NewsFeed,
28 May 2008:
Biopharmaceuticals
[Amgen, denosumab, alendronate, FOSAMAX, Merck, Osteoporosis]
|
Daiichi Sankyo Co., Ltd. Announces Acquisition of Biotech Firm U3 Pharma AG
HSMN NewsFeed,
21 May 2008:
Biopharmaceuticals, Mergers & Acquisitions
[Daiichi Sankyo, U3 Pharma AG]
|
Denosumab Osteoporosis Study Meets Primary and All Secondary Bone Mineral Density Endpoints in Alendronate (FOSAMAX(R)) Transition Study
HSMN NewsFeed,
19 May 2008:
Biopharmaceuticals
[Amgen, denosumab, alendronate, FOSAMAX, bone mineral density]
|
AMAG Pharmaceuticals, Inc. Announces Appointment of Robert M. Brenner, M.D. as Senior Vice President of Medical Affairs
HSMN NewsFeed,
19 May 2008:
Biopharmaceuticals, Personnel
[AMAG Pharmaceuticals]
|
Phase 3 GATTEX(TM) Results Presented at Annual Digestive Disease Week Congress Highlight Potential New Treatment in Short Bowel Syndrome
HSMN NewsFeed,
19 May 2008:
Biopharmaceuticals, Gastroenterology
[NPS Pharmaceuticals, GATTEX, teduglutide, short bowel syndrome]
|
MedImmune Fortifies Strategic Scientific Portfolio Management and International Leadership With New Executive Appointments
HSMN NewsFeed,
6 May 2008:
Biopharmaceuticals, Personnel
[MedImmune]
|
Eisai Corporation of North America Announces Appointment of Cynthia Schwalm as President, Eisai Inc.
HSMN NewsFeed,
5 May 2008:
Biopharmaceuticals, Personnel
[Eisai]
|
FDA Approval of Cimzia(R) for Crohn's Disease Represents Latest Milestone for Nektar's PEGylation Technology Platform
HSMN NewsFeed,
23 Apr 2008:
Biopharmaceuticals, Gastroenterology, FDA
[Nektar Therapeutics, UCB, Cimzia, certolizumab, Crohn's disease]
|
Stiefel Laboratories Appoints First Chief Scientific Officer
HSMN NewsFeed,
7 Apr 2008:
Biopharmaceuticals, Dermatology, Personnel
[Stiefel Laboratories]
|
Pivotal Phase 3 Data Show Denosumab Increased Bone Density at Multiple Skeletal Sites in Early and Later Stage Postmenopausal Women
HSMN NewsFeed,
2 Apr 2008:
Biopharmaceuticals
[Amgen, osteoporosis, denosumab]
|
Breathe Technologies, Inc. Closes on $15 Million in Venture Funding Led by Kleiner Perkins Caufield & Byers
HSMN NewsFeed,
26 Mar 2008:
Devices, Venture Capital
[Breathe Technologies, COPD, cystic fibrosis]
|
Medivation Announces Senior Management Promotions
HSMN NewsFeed,
25 Mar 2008:
Biopharmaceuticals, Personnel
[Medivation]
|
Pharming signs distribution agreement for Rhucin(R) in Turkey
HSMN NewsFeed,
25 Mar 2008:
Biopharmaceuticals, Distribution
[Pharming Group, Eczacibasi Group, Rhucin, Hereditary Angioedema]
|
NPS Reports Successful GATTEX(TM) Extension Study
HSMN NewsFeed,
17 Mar 2008:
Biopharmaceuticals, Gastroenterology
[NPS Pharmaceuticals, GATTEX, teduglutide, short bowel syndrome]
|
Amgen and Wyeth Announce Updates to U.S. Prescribing Information for Enbrel(R)
HSMN NewsFeed,
17 Mar 2008:
Biopharmaceuticals
[Amgen, Wyeth Pharmaceuticals, Enbrel, etanercept]
|
Amgen to Discuss Benefits and Risks of ESA Treatment for Cancer Patients with Anemia Due to Chemotherapy at FDA ODAC Meeting
HSMN NewsFeed,
13 Mar 2008:
Biopharmaceuticals, Oncology, FDA
[Amgen, Erythropoiesis-stimulating Agent, Aranesp, darbepoetin alfa]
|
Amgen Statement on Successful Outcome of Romiplostim Panel Meeting
HSMN NewsFeed,
12 Mar 2008:
Biopharmaceuticals, Oncology, FDA
[Amgen, romiplostim, thrombocytopenia, immune thrombocytopenic purpura]
|
Memory Pharmaceuticals Refocuses to Advance Development and Clinical Programs
HSMN NewsFeed,
12 Mar 2008:
Biopharmaceuticals
[Memory Pharmaceuticals, Amgen, Roche Group]
|
Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa)
HSMN NewsFeed,
7 Mar 2008:
Biopharmaceuticals
[Ortho Biotech Products, PROCRIT, Epoetin alfa, erythropoiesis-stimulating agent]
|
FDA Approves New Drug Application (NDA) for LEVOleucovorin, Spectrum's First Proprietary Oncology Drug
HSMN NewsFeed,
7 Mar 2008:
Biopharmaceuticals, Oncology, FDA
[Spectrum Pharmaceuticals, Levoleucovorin, methotrexate, leucovorin, osteosarcoma]
|
Amgen Announces Update to U.S. Prescribing Information for Aranesp(R) and EPOGEN(R)
HSMN NewsFeed,
7 Mar 2008:
Biopharmaceuticals, FDA
[Amgen, Aranesp, darbepoetin alfa, EPOGEN, erythropoiesis-stimulating agents]
|
Kyowa Hakko and Amgen Enter Licensing Agreement for Anti-CCR4 Humanized Monoclonal Antibody
HSMN NewsFeed,
5 Mar 2008:
Biopharmaceuticals, Licensing
[Amgen, Kyowa Hakko, KW-0761, monoclonal antibody]
|
EU Commission Approves Updated Prescribing Information for Aranesp(R)
HSMN NewsFeed,
5 Mar 2008:
Biopharmaceuticals, Regulatory
[Amgen, Aranesp, darbepoetin alfa, Erythropoiesis Stimulating Agent]
|
Pfizer Names William Ringo Senior Vice President of Strategy and Business Development
HSMN NewsFeed,
3 Mar 2008:
Biopharmaceuticals, Personnel
[Pfizer]
|
NPS Pharmaceuticals Announces Senior Management Changes
HSMN NewsFeed,
26 Feb 2008:
Biopharmaceuticals, Personnel
[NPS Pharmaceuticals]
|
BiPar Names Hoyoung Huh, M.D., Ph.D. President and Chief Executive Officer
HSMN NewsFeed,
14 Feb 2008:
Biopharmaceuticals, Personnel
[BiPar Sciences]
|
Calistoga Pharmaceuticals Announces Appointment of R. Lee Douglas, 22-Year Biotechnology/Pharmaceutical Industry Veteran, to Its Board of Directors
HSMN NewsFeed,
13 Feb 2008:
Biopharmaceuticals, Personnel
[Calistoga Pharmaceuticals]
|
Abraxis Bioscience Establishes Global Leadership Team
HSMN NewsFeed,
7 Feb 2008:
Biopharmaceuticals, Personnel
[Abraxis BioScience]
|
Amgen and Takeda Announce Exclusive Collaboration in Japan on up to 13 Amgen Clinical Candidates
HSMN NewsFeed,
4 Feb 2008:
Biopharmaceuticals, Licensing
[Amgen, Takeda Pharmaceutical, Motesanib, Vectibix, panitumumab]
|
Gloucester Pharmaceuticals Announces New Senior Management Team
HSMN NewsFeed,
28 Jan 2008:
Biopharmaceuticals, Personnel
[Gloucester Pharmaceuticals]
|
Denosumab Osteoporosis Study Met Primary and All Secondary Bone Mineral Density Endpoints in a Head-to-Head Comparison with Weekly Alendronate (FOSAMAX(R))
HSMN NewsFeed,
24 Jan 2008:
Biopharmaceuticals
[Amgen, denosumab, alendronate, FOSAMAX, Osteoporosis]
|
KRAS Gene Status May Impact Vectibix(TM) (Panitumumab) Efficacy and Patient Reported Outcomes in Advanced Colorectal Cancer Patients
HSMN NewsFeed,
24 Jan 2008:
Biopharmaceuticals, Oncology
[Amgen, metastatic colorectal cancer, Vectibix, panitumumab, KRAS tumors]
|
Myriad Genetics, Inc. Expands Commercial and Clinical Infrastructure
HSMN NewsFeed,
23 Jan 2008:
Biopharmaceuticals, Personnel
[Myriad Genetics]
|
Alfacell Appoints David Sidransky Chairman of the Board of Directors
HSMN NewsFeed,
17 Jan 2008:
Biopharmaceuticals, Personnel
[Alfacell, ONCONASE, David Sidransky]
|
New Study Shows Biologic Therapy Enbrel(R) (etanercept) Effective in Treating Psoriasis in Children and Adolescents
HSMN NewsFeed,
16 Jan 2008:
Biopharmaceuticals
[Wyeth Pharmaceuticals, Amgen, psoriasis, Enbrel, etanercept]
|
New Study Reports Enbrel(R) (Etanercept) Significantly Improved Moderate to Severe Plaque Psoriasis in Children and Adolescents
HSMN NewsFeed,
16 Jan 2008:
Biopharmaceuticals
[Amgen, Wyeth Pharmaceuticals, Wyeth, ENBREL, etanercept, psoriasis]
|
Three Rivers Pharmaceuticals(R), LLC Acquires Hepatitis C Drug Infergen(R) from Valeant Pharmaceuticals
HSMN NewsFeed,
14 Jan 2008:
Biopharmaceuticals, Acquisitions
[Three Rivers Pharmaceuticals, Valeant Pharmaceuticals, hepatitis C , Infergen]
|
Anthera Pharmaceuticals Acquires the Worldwide Rights to a BAFF Inhibitor for the Treatment of Lupus and Other Autoimmune Diseases
HSMN NewsFeed,
8 Jan 2008:
Biopharmaceuticals, Licensing
[Anthera Pharmaceuticals, Amgen, AMG 623, lupus]
|
Exelixis Announces Senior Management Promotions
HSMN NewsFeed,
4 Jan 2008:
Biopharmaceuticals, Personnel
[Exelixis]
|
Calistoga Pharmaceuticals Announces Completion of Its Series A Financing -- Investors Increased Funding by 25% to Total $26.2 Million
HSMN NewsFeed,
3 Jan 2008:
Biopharmaceuticals, Venture Capital
[Calistoga Pharmaceuticals]
|
MedImmune Expands Scientific and Engineering Leadership
HSMN NewsFeed,
20 Dec 2007:
Biopharmaceuticals, Personnel
[MedImmune]
|
Valeant Pharmaceuticals Sells Hep-C Drug Infergen(R) to Three Rivers Pharmaceuticals(R), LLC for $91 Million
HSMN NewsFeed,
20 Dec 2007:
Biopharmaceuticals, Acquisitions
[Valeant Pharmaceuticals, Three Rivers Pharmaceuticals, hepatitis C , Infergen]
|
New Drug to Prevent Bone Loss Caused by Breast Cancer Treatment
HSMN NewsFeed,
15 Dec 2007:
Biopharmaceuticals, Oncology
[Amgen, denosumab, breast cancer]
|
Pivotal Phase 3 Data Show Denosumab Increased Bone Density Throughout Skeleton in Non-Metastatic Breast Cancer Patients on Adjuvant Aromatase Inhibitor Therapy
HSMN NewsFeed,
14 Dec 2007:
Biopharmaceuticals, Oncology
[Amgen, denosumab, breast cancer]
|
Pivotal Phase 3 NPLATE(TM) Study in Non-Splenectomized Patients Met Primary Endpoints
HSMN NewsFeed,
10 Dec 2007:
Biopharmaceuticals
[Amgen, Nplate, romiplostim, Immune Thrombocytopenic Purpura]
|
Pivotal Phase 3 Romiplostim Study in Splenectomized Patients Meets Primary Endpoints
HSMN NewsFeed,
8 Dec 2007:
Biopharmaceuticals
[Amgen, romiplostim, AMG 531, Immune Thrombocytopenic Purpura]
|
Amgen in Discussions with FDA to Update U.S. Prescribing Information for ESAs
HSMN NewsFeed,
6 Dec 2007:
Biopharmaceuticals
[Amgen, erythropoiesis, Aranesp]
|
Vectibix(R) Approved in the European Union for the Treatment of Metastatic Colorectal Cancer
HSMN NewsFeed,
5 Dec 2007:
Biopharmaceuticals, Oncology, Regulatory
[Amgen, Vectibix, panitumumab, EGFr, KRAS, metastatic colorectal cancer]
|
Kythera Biopharmaceuticals Appoints Amgen Veteran as Chief Financial Officer
HSMN NewsFeed,
29 Nov 2007:
Biopharmaceuticals, Personnel
[Kythera Biopharmaceuticals]
|
Skyline Ventures Closes $350 Million Healthcare Fund
HSMN NewsFeed,
14 Nov 2007:
Venture Capital
[Skyline Ventures]
|
InteKrin Therapeutics, Inc. Appoints Former Amgen Clinical Development Executive Chief Medical Officer
HSMN NewsFeed,
8 Nov 2007:
Biopharmaceuticals, Personnel
[InteKrin Therapeutics]
|
Amgen Announces Updates to the U.S. Prescribing Information for ESAs
HSMN NewsFeed,
8 Nov 2007:
Biopharmaceuticals, FDA
[Amgen, Aranesp, darbepoetin, Johnson and Johnson, PROCRIT, Epoetin]
|
OncoMed Appoints William D. Waddill Senior Vice President and Chief Financial Officer
HSMN NewsFeed,
30 Oct 2007:
Biopharmaceuticals, Personnel
[OncoMed Pharmaceuticals]
|
Relypsa Formed With $33 Million Series A Funding to Discover and Develop Polymeric Drugs
HSMN NewsFeed,
29 Oct 2007:
Biopharmaceuticals, Venture Capital
[Relypsa, hyperkalemia, heart failure]
|
Allozyne, Inc., Closes $30 Million Series B Financing and Appoints Meenu Chhabra as President and Chief Executive Officer
HSMN NewsFeed,
26 Oct 2007:
Biopharmaceuticals, Venture Capital, Personnel
[Allozyne, Multiple Sclerosis]
|
Roche Considering Legal Options In Patent Litigation Case
HSMN NewsFeed,
23 Oct 2007:
Biopharmaceuticals, Litigation
[Roche Group, Amgen, epoetin, MIRCERA, erythropoiesis-stimulating agent]
|
Jury Rules Roche Infringes Amgen's EPO Patents
HSMN NewsFeed,
23 Oct 2007:
Biopharmaceuticals, Litigation
[Amgen, EPOGEN, Aranesp, Roche Group, erythropoietin]
|
Dr. David Sidransky Appointed Chairman of Champions Biotechnology, Inc.
HSMN NewsFeed,
23 Oct 2007:
Biopharmaceuticals, Personnel
[Champions Biotechnology]
|
Metastatix Appoints Carol G. Gallagher, Pharm.D. as President and Chief Executive Officer
HSMN NewsFeed,
16 Oct 2007:
Biopharmaceuticals, Personnel
[Metastatix]
|
Velcura Therapeutics, Inc. Appoints Industry Executive to Lead Regulatory Affairs
HSMN NewsFeed,
15 Oct 2007:
Biopharmaceuticals, Personnel
[Velcura Therapeutics]
|
Anaptys Biosciences Appoints R. Scott Greer to Board of Directors
HSMN NewsFeed,
8 Oct 2007:
Biopharmaceuticals, Personnel
[Anaptys Biosciences]
|
Cellectar Expands Clinical Management Team
HSMN NewsFeed,
3 Oct 2007:
Biopharmaceuticals, Oncology, Personnel
[Cellectar, radiotherapy, radiopharmaceutical]
|
Amgen Receives Proposal for Amending EU Prescribing Information for Aranesp(R)
HSMN NewsFeed,
27 Sep 2007:
Biopharmaceuticals, Regulatory
[Amgen, epoetins, Erythropoiesis Stimulating Agents, Aranesp, darbepoetin alfa]
|
EnVivo Pharmaceuticals Announces Executive Appointment
HSMN NewsFeed,
26 Sep 2007:
Biopharmaceuticals, Personnel
[EnVivo Pharmaceuticals]
|
Osprey Pharmaceuticals Names Jack M. Anthony as CEO
HSMN NewsFeed,
26 Sep 2007:
Biopharmaceuticals, Personnel
[Osprey Pharmaceuticals]
|
New Analysis Suggests First Cycle Use of Neulasta(R) Reduces Febrile Neutropenia Hospitalizations and Chemotherapy Dose Reductions in Breast Cancer Patients Compared to Current Practice
HSMN NewsFeed,
26 Sep 2007:
Biopharmaceuticals, Oncology
[Amgen, Neulasta, pegfilgrastim]
|
Morria Biopharmaceuticals Plc Appoints Dr. Johnson Lau and Dr. David Sidransky to Board of Directors
HSMN NewsFeed,
25 Sep 2007:
Biopharmaceuticals, Personnel
[Morria Biopharmaceuticals]
|
New Biomarker Data Links KRAS Gene to Vectibix(TM) Clinical Response
HSMN NewsFeed,
25 Sep 2007:
Biopharmaceuticals, Oncology
[Amgen, Vectibix, panitumumab, KRAS , metastatic colorectal cancer]
|
Aranesp(R) DAHANCA 10 Study Results Presented at ECCO Annual Meeting
HSMN NewsFeed,
25 Sep 2007:
Biopharmaceuticals, Oncology
[Amgen, Aranesp, darbepoetin alfa, DAHANCA study]
|
Nodality Names David R. Parkinson, MD as Its CEO
HSMN NewsFeed,
24 Sep 2007:
Diagnostics, Personnel
[Nodality]
|
Vectibix(TM) (panitumumab) Receives Positive Opinion for Marketing Authorization in the European Union
HSMN NewsFeed,
21 Sep 2007:
Biopharmaceuticals, Oncology, Regulatory
[Amgen, Vectibix, panitumumab, colorectal cancer]
|
CG Therapeutics Appoints Dr. Christopher S. Henney as Chairman of Board of Directors
HSMN NewsFeed,
20 Sep 2007:
Biopharmaceuticals, Personnel
[CG Therapeutics]
|
Morria Biopharmaceuticals Plc Announces Appointment of Dr. Rosemary Mazanet as Interim Chief Executive Officer
HSMN NewsFeed,
18 Sep 2007:
Biopharmaceuticals, Personnel
[Morria Biopharmaceuticals]
|
Amgen to Review Benefits, Risks of ESA Therapy in Chronic Renal Failure Patients at FDA Advisory Committee
HSMN NewsFeed,
11 Sep 2007:
Biopharmaceuticals
[Amgen, Erythropoiesis Stimulating Agent, Chronic Renal Failure, Aranesp]
|
Aranesp(R) Study Showing No Negative Impact on Survival in SCLC Presented at World Conference on Lung Cancer
HSMN NewsFeed,
6 Sep 2007:
Biopharmaceuticals, Oncology
[Amgen, Aranesp, darbepoetin alfa, AMG 706]
|
EPIX Pharmaceuticals Appoints Margaret Uprichard, Pharm.D. as Senior Vice President, Regulatory Affairs & Quality
HSMN NewsFeed,
21 Aug 2007:
Biopharmaceuticals, Personnel
[EPIX Pharmaceuticals]
|
Vical Names Andrew de Guttadauro Vice President, Corporate Development
HSMN NewsFeed,
20 Aug 2007:
Biopharmaceuticals, Personnel
[Vical Inc]
|
Amgen Restructures Due to Lower Aranesp(R) Revenues While Continuing to Invest in Innovation and Future Growth
HSMN NewsFeed,
15 Aug 2007:
Biopharmaceuticals
[Amgen, Aranesp, darbepoetin alfa]
|
Nereus Pharmaceuticals Raises $45 Million in Series D-2 Financing
HSMN NewsFeed,
9 Aug 2007:
Biopharmaceuticals, Venture Capital
[Nereus Pharmaceuticals]
|
Dennis Fenton, Executive Vice President of Operations, Elects to Retire after 25 Years with Amgen
HSMN NewsFeed,
1 Aug 2007:
Biopharmaceuticals, Personnel
[Amgen]
|
OXiGENE Appoints Patricia Walicke, M.D., Ph.D. as Chief Medical Officer
HSMN NewsFeed,
31 Jul 2007:
Biopharmaceuticals, Personnel
[OXiGENE]
|
Amira Pharmaceuticals Announces Appointment of First Chief Executive Officer
HSMN NewsFeed,
30 Jul 2007:
Biopharmaceuticals, Personnel
[Amira Pharmaceuticals]
|
Auriga Laboratories Appoints Lisa Tripodi as Vice President of Trade Relations
HSMN NewsFeed,
20 Jul 2007:
Biopharmaceuticals, Personnel
[Auriga Laboratories]
|
Agensys Raises $41 Million
HSMN NewsFeed,
12 Jul 2007:
Biopharmaceuticals, Oncology, Venture Capital
[Agensys]
|
Abeome Ramps up Antibody Commercialization
HSMN NewsFeed,
9 Jul 2007:
Biopharmaceuticals, Venture Capital
[Abeome Corp, monoclonal antibody]
|
Renovis Announces Management Changes
HSMN NewsFeed,
28 Jun 2007:
Biopharmaceuticals, Personnel
[Renovis]
|
Amgen Submits Testimony to House Ways & Means Committee
HSMN NewsFeed,
26 Jun 2007:
Biopharmaceuticals, Reimbursement
[Amgen, EPOGEN, Epoetin alfa]
|
Merrimack Pharmaceuticals Names Lisa Evren Senior Vice President and Chief Financial Officer
HSMN NewsFeed,
26 Jun 2007:
Biopharmaceuticals, Personnel
[Merrimack Pharmaceuticals]
|
Argolyn Bioscience Raises $15.8 Million Round of Financing
HSMN NewsFeed,
25 Jun 2007:
Biopharmaceuticals, Venture Capital
[Argolyn Bioscience]
|
Experienced Biopharmaceutical Executive Steve Glover Joins Insmed; Will Lead Development of Follow-on Biologics
HSMN NewsFeed,
25 Jun 2007:
Biopharmaceuticals, Personnel
[Insmed]
|
Cytokinetics Announces Second Extension of Research Term Under Collaboration With GlaxoSmithKline
HSMN NewsFeed,
19 Jun 2007:
Biopharmaceuticals, Oncology
[Cytokinetics, GlaxoSmithKline, centromere-associated protein]
|
Oragenics Appoints Dr. Ronald P. Evens to Its Board of Directors
HSMN NewsFeed,
18 Jun 2007:
Biopharmaceuticals, Personnel
[Oragenics]
|
Seattle Genetics Adds Industry Veterans John P. McLaughlin and Daniel G. Welch to its Board of Directors and Promotes Eric Dobmeier to Chief Business Officer
HSMN NewsFeed,
14 Jun 2007:
Biopharmaceuticals, Oncology, Personnel
[Seattle Genetics]
|
Anacor Names Paulette Dillon as Chief Business Officer
HSMN NewsFeed,
14 Jun 2007:
Biopharmaceuticals, Personnel
[Anacor Pharmaceuticals]
|
CEL-SCI Receives US FDA Orphan Drug Designation for Its Cancer Drug Multikine(R)
HSMN NewsFeed,
12 Jun 2007:
Biopharmaceuticals, Oncology, FDA
[CEL-SCI Corp, Multikine, head and neck cancer]
|
Amgen to Acquire Alantos Pharmaceuticals, a Private Biotechnology Company in Cambridge, Massachusetts
HSMN NewsFeed,
6 Jun 2007:
Biopharmaceuticals, Mergers & Acquisitions
[Amgen, Alantos Pharmaceuticals]
|
Nventa hires Vice President of Corporate Development
HSMN NewsFeed,
5 Jun 2007:
Biopharmaceuticals, Personnel
[Nventa Biopharmaceuticals]
|
Cytokinetics Announces the Presentation of Clinical Trials Data at the 2007 Annual Meeting of the American Society of Clinical Oncology
HSMN NewsFeed,
4 Jun 2007:
Biopharmaceuticals, Oncology
[Cytokinetics, Ispinesib, SB-743921, kinesin spindle protein, GlaxoSmithKline]
|
Genentech Provides Update on Pipeline Agents at the American Society of Clinical Oncology Meeting
HSMN NewsFeed,
3 Jun 2007:
Biopharmaceuticals, Oncology
[Genentech, Pertuzumab, Trastuzumab-DM1, Apomab, Apo2L/TRAIL]
|
Amgen to Appeal CHMP Opinion on Vectibix(TM) (Panitumumab)
HSMN NewsFeed,
25 May 2007:
Biopharmaceuticals, Oncology, Regulatory
[Amgen, Vectibix, panitumumab, metastatic colorectal cancer]
|
Amgen Names David Lacey, M.D., Senior Vice President, Head of Research
HSMN NewsFeed,
22 May 2007:
Biopharmaceuticals, Personnel
[Amgen]
|
Halozyme Therapeutics Names Randal J. Kirk and Kathryn E. Falberg to Board of Directors
HSMN NewsFeed,
16 May 2007:
Biopharmaceuticals, Personnel
[Halozyme Therapeutics]
|
Cougar Biotechnology Announces Additions to Clinical Research and Development Team
HSMN NewsFeed,
15 May 2007:
Biopharmaceuticals, Oncology, Personnel
[Cougar Biotechnology]
|
Former Immunex Management Team Chosen to Head-Up CTI Subsidiary Aequus BioPharma, Inc.
HSMN NewsFeed,
14 May 2007:
Biopharmaceuticals, Personnel
[Cell Therapeutics, Aequus BioPharma]
|
Spiration, Inc. Names Nancy Hill Vice President, Marketing to Strengthen Market Development and Global Product Commercialization Initiatives
HSMN NewsFeed,
9 May 2007:
Devices, Personnel
[ Spiration]
|
Bill Cadwallader Joins Velcura Therapeutics, Inc. as Executive Vice President of Corporate Development
HSMN NewsFeed,
7 May 2007:
Biopharmaceuticals, Personnel
[Velcura Therapeutics]
|
Royalty Pharma Acquires a Portion of New York University's Royalty Interest in Remicade(R) for $650 Million
HSMN NewsFeed,
4 May 2007:
Biopharmaceuticals
[Royalty Pharma, Remicade]
|
Anaptys Biosciences Names Former Xoma Executive as Chairman and CEO
HSMN NewsFeed,
30 Apr 2007:
Biopharmaceuticals, Personnel
[Anaptys Biosciences, Tom Smart]
|
Osprey Pharmaceuticals Limited Appoints Jack M. Anthony to the Newly Created Position of Senior Vice President, Corporate Development
HSMN NewsFeed,
24 Apr 2007:
Biopharmaceuticals, Personnel
[Osprey Pharmaceuticals]
|
Aranesp(R) ``145 Study'' Shows No Difference in Survival in Patients with Small-Cell Lung Cancer
HSMN NewsFeed,
19 Apr 2007:
Biopharmaceuticals, Oncology
[Amgen, 145 study, Aranesp, darbepoetin alfa]
|
Sunesis Pharmaceuticals Appoints Valerie L. Pierce Senior Vice President, General Counsel and Corporate Secretary
HSMN NewsFeed,
17 Apr 2007:
Biopharmaceuticals, Personnel
[Sunesis Pharmaceuticals]
|
Aranesp(R) Phase 3 Study in Patients with Active Cancer Not Receiving Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual Meeting
HSMN NewsFeed,
16 Apr 2007:
Biopharmaceuticals, Oncology
[Amgen, Aranesp, darbepoetin alfa, anemia]
|
ARIAD files claim against Amgen and Wyeth Alleging Infringement of NF-(kappa)B Patent by Enbrel(R) and Kineret(R)
HSMN NewsFeed,
13 Apr 2007:
Biopharmaceuticals, Litigation
[ARIAD Pharmaceuticals, Amgen, Wyeth, Enbrel, etanercept, Kineret, anakinra]
|
Amgen Names Robert Bradway Executive Vice President and Chief Financial Officer
HSMN NewsFeed,
10 Apr 2007:
Biopharmaceuticals, Personnel
[Amgen]
|
Innovative Pulmonary and PEGylation-Based Therapeutic Product Development Drives Business Strategy of Nektar Therapeutics
HSMN NewsFeed,
9 Apr 2007:
Biopharmaceuticals, Personnel
[Nektar Therapeutics, PEGylation]
|
EPIX Provides Update Regarding Status of Vasovist(TM) Appeal
HSMN NewsFeed,
2 Apr 2007:
Biopharmaceuticals, Radiology, FDA
[EPIX Pharmaceuticals, Vasovist, gadofosveset, imaging agent]
|
Amgen Discontinues Vectibix(TM) Treatment in Pacce Trial Evaluating Vectibix(Tm) as Part of Triple Combination Regimen
HSMN NewsFeed,
22 Mar 2007:
Biopharmaceuticals, Oncology
[Amgen, Vectibix, panitumumab, PACCE trial, colorectal cancer]
|
AVANIR Pharmaceuticals Appoints New Chief Executive Officer
HSMN NewsFeed,
14 Mar 2007:
Biopharmaceuticals, Personnel
[ AVANIR Pharmaceuticals]
|
Amgen Announces Update To U.S. Prescribing Information for Aranesp(R) and EPOGEN(R)
HSMN NewsFeed,
9 Mar 2007:
Biopharmaceuticals, Oncology, FDA
[Amgen, Aranesp, darbepoetin alfa, EPOGEN, Epoetin alfa]
|
Oncologic Appoints Stephen T. Isaacs as President and Chief Executive Officer
HSMN NewsFeed,
6 Mar 2007:
Biopharmaceuticals, Oncology, Personnel
[Oncologic Inc]
|
NCCN Updates Cancer- and Treatment-Related Anemia Guidelines
HSMN NewsFeed,
5 Mar 2007:
Oncology
[NCCN, Aranesp, darbepoetin, Amgen]
|
Calistoga Pharmaceuticals, A Newly Formed Drug Development Company, Announces Its Formation and Completion of a $21 Million Series A Financing
HSMN NewsFeed,
5 Mar 2007:
Biopharmaceuticals, Venture Capital
[Calistoga Pharmaceuticals]
|
Prime Minister Tony Blair Opens Major Amgen Development Centre in London
HSMN NewsFeed,
2 Mar 2007:
Biopharmaceuticals
[Amgen]
|
EPIX Pharmaceuticals Files Formal Appeal for Vasovist(TM) with the Center for Drug Evaluation and Research
HSMN NewsFeed,
28 Feb 2007:
Biopharmaceuticals, FDA
[EPIX Pharmaceuticals, Vasovist, gadofosveset]
|
NCCN Updates Myelodysplastic Syndromes (MDS) Guidelines
HSMN NewsFeed,
26 Feb 2007:
Biopharmaceuticals, Oncology
[NCCN, Myelodysplastic Syndromes, Aranesp, Vidaza, Dacogen]
|
PDL BioPharma Announces New Chief Medical Officer and Appoints Chief Scientific Officer to Its Board of Directors
HSMN NewsFeed,
20 Feb 2007:
Biopharmaceuticals, Personnel
[PDL BioPharma]
|
Locus Pharmaceuticals Completes $30.2 Million Financing Round
HSMN NewsFeed,
13 Feb 2007:
Biopharmaceuticals, Venture Capital
[Locus Pharmaceuticals]
|
EPIX Pharmaceuticals Presents Data from Novel MRI Imaging Agent at the Society for Cardiovascular Magnetic Resonance Meeting
HSMN NewsFeed,
5 Feb 2007:
Biopharmaceuticals, Radiology, Cardiology
[EPIX Pharmaceuticals, EP-3533, gadolinium, magnetic resonance imaging]
|
Survey Indicates People with Chronic Moderate to Severe Plaque Psoriasis May Be Under-Treated
HSMN NewsFeed,
2 Feb 2007:
Biopharmaceuticals, Dermatology
[Amgen, psoriasis, plaque psoriasis]
|
Fresenius Medical Care and Amgen Enter New Commercial Collaboration in Europe
HSMN NewsFeed,
1 Feb 2007:
Biopharmaceuticals
[Fresenius Medical Care, Amgen Europe, Amgen, Aranesp, darbepoetin alfa]
|
Fresenius Medical Care and Amgen Establish a Joint Research Program in Europe
HSMN NewsFeed,
1 Feb 2007:
Biopharmaceuticals
[Fresenius Medical Care, Amgen Europe, Amgen]
|
TetraLogic Pharmaceuticals Appoints Dr. Andrew Pecora to Its Board of Directors
HSMN NewsFeed,
30 Jan 2007:
Biopharmaceuticals, Personnel
[TetraLogic Pharmaceuticals]
|
NCCN Updates Colon Cancer Guidelines
HSMN NewsFeed,
29 Jan 2007:
Biopharmaceuticals, Oncology
[NCCN, capecitabine, Xeloda, Roche , oxaliplatin, Eloxatin, sanofi-aventis]
|
Cytokinetics Announces Changes to its Executive Management Team and Board of Directors
HSMN NewsFeed,
22 Jan 2007:
Biopharmaceuticals, Personnel
[Cytokinetics]
|
InteKrin Therapeutics Secures $23 M Venture Financing
HSMN NewsFeed,
11 Jan 2007:
Biopharmaceuticals, Venture Capital
[InteKrin Therapeutics]
|
InteKrin Therapeutics Licenses Diabetes Product
HSMN NewsFeed,
10 Jan 2007:
Biopharmaceuticals, Endocrinology, Licensing
[InteKrin Therapeutics, Amgen, INT131, AMG131, Tularik, diabetes]
|
Seattle Genetics and Agensys Announce Collaboration to Co-Develop and Commercialize Antibody-Drug Conjugate Therapies for Cancer
HSMN NewsFeed,
8 Jan 2007:
Biopharmaceuticals, Licensing
[Seattle Genetics, Agensys]
|
ChemoCentryx Appoints Juan Jaen, Ph.D., Senior Vice President, Drug Discovery
HSMN NewsFeed,
4 Jan 2007:
Biopharmaceuticals, Personnel
[ChemoCentryx]
|
Cytokinetics and Amgen Announce Strategic Alliance in Heart Failure
HSMN NewsFeed,
3 Jan 2007:
Biopharmaceuticals, Cardiology
[Amgen, Cytokinetics, CK-1827452]
|
CoGenesys Files to Begin Clinical Trials of Neugranin for the Prevention of Infections in Cancer Patients
HSMN NewsFeed,
3 Jan 2007:
Biopharmaceuticals
[CoGenesys, Neugranin]
|
ImmunoGen, Inc. Announces that sanofi-aventis Has Entered into an Option Agreement for Expanded Access to the Company's TAP Technology
HSMN NewsFeed,
26 Dec 2006:
Biopharmaceuticals, Drug Delivery, Licensing
[ImmunoGen, Tumor-Activated Prodrug, sanofi-aventis]
|
GlaxoSmithKline and Genmab Enter Global Agreement For HuMax-CD20
HSMN NewsFeed,
19 Dec 2006:
Biopharmaceuticals, Oncology
[Genmab, GlaxoSmithKline, HuMax- CD20, ofatumumab, B-CLL, non-Hodgkin's lymphoma]
|
Lipoxen Announces $75M Agreement With Baxter to Develop New Blood Clotting Factors
HSMN NewsFeed,
15 Dec 2006:
Biopharmaceuticals, Drug Delivery, Licensing
[Lipoxen, Baxter, clotting factor, PolyXen]
|
EPIX Pharmaceuticals to File Appeal with the Center for Drug Evaluation and Research for Vasovist(TM)
HSMN NewsFeed,
14 Dec 2006:
Biopharmaceuticals, FDA
[EPIX Pharmaceuticals, Vasovist, gadofosveset]
|
Valeant Pharmaceuticals Initiates Infergen(R) Phase 4 Study
HSMN NewsFeed,
12 Dec 2006:
Biopharmaceuticals
[Valeant Pharmaceuticals, Infergen, Consensus Interferon, hepatitis C]
|
Celgene Appoints Thomas O. Daniel, M.D. as President of Global Research
HSMN NewsFeed,
7 Dec 2006:
Biopharmaceuticals, Personnel
[Celgene]
|
Amgen Submits Testimony to House Ways & Means Committee
HSMN NewsFeed,
6 Dec 2006:
Biopharmaceuticals
[Amgen, EPOGEN, Epoetin alfa]
|
Amgen Names Yuji Orihara President, Amgen KK
HSMN NewsFeed,
1 Dec 2006:
Biopharmaceuticals, Personnel
[Amgen, Amgen KK, Yuji Orihara]
|
Intradigm Announces Significant Enhancements of the Company Capabilities, a New Series A Financing and Important Addition to Senior Management Team
HSMN NewsFeed,
21 Nov 2006:
Biopharmaceuticals, Personnel, Venture Capital
[Intradigm, RNA interference]
|
Data Shows ENBREL Provides Sustained Clinical Improvements for People with Ankylosing Spondylitis for up to Three Years
HSMN NewsFeed,
13 Nov 2006:
Biopharmaceuticals
[Amgen, ankylosing spondylitis, Enbrel, etanercept]
|
ENBREL is the First Biologic to Publish Data Showing Safety and Sustained Efficacy for up to Nine Years in Patients with Moderate-to-Severe Rheumatoid Arthritis
HSMN NewsFeed,
12 Nov 2006:
Biopharmaceuticals
[Amgen, Enbrel, etanercept, rheumatoid arthritis]
|
Naryx Pharma, Inc. Announces the Election of Geron Corporation Executive Alan B. Colowick to its Board of Directors
HSMN NewsFeed,
7 Nov 2006:
Biopharmaceuticals, Personnel
[Naryx Pharma]
|
EPIX Announces Canadian Approval of Vasovist(TM); Marks 30th Country in Which Vasovist is Approved for Marketing
HSMN NewsFeed,
6 Nov 2006:
Biopharmaceuticals, Regulatory, Radiology
[EPIX Pharmaceuticals, Vasovist, gadofosveset, contrast agent]
|
AMG 706 Shows Activity in Phase 2 Study of Patients with Advanced Imatinib-Resistant Gastrointestinal Stromal Tumors
HSMN NewsFeed,
4 Nov 2006:
Biopharmaceuticals, Oncology
[Amgen, AMG 706, VEGF receptor inhibitor, gastrointestinal stromal tumor]
|
Introgen Obtains Exclusive License to Therapies Combining Epidermal Growth Factor Drugs and Tumor Suppressor Genes
HSMN NewsFeed,
3 Nov 2006:
Biopharmaceuticals, Licensing, Oncology
[Introgen Therapeutics, ADVEXIN, Erbitux, Vectibix, Tarceva, Iressa]
|
Prominent Oncologist, Dr. David Sidransky, Joins Zila Board
HSMN NewsFeed,
31 Oct 2006:
Diagnostics, Personnel
[ Zila]
|
Jody LoMenzo Named Director, Investor Relations and Corporate Communications
HSMN NewsFeed,
31 Oct 2006:
Biopharmaceuticals, Personnel
[Insmed]
|
Valeant Pharmaceuticals Presents End-of-Treatment Results of DIRECT Trial for Infergen at the American Association for the Study of Liver Diseases 2006 Annual Meeting
HSMN NewsFeed,
30 Oct 2006:
Biopharmaceuticals
[Valeant Pharmaceuticals, Infergen, Consensus Interferon, hepatitis C]
|
Maxygen to Receive $17.8 Million From Acquisition of Avidia by Amgen
HSMN NewsFeed,
27 Oct 2006:
Biopharmaceuticals, Mergers & Acquisitions
[Maxygen, Avidia, Amgen, Avimer protein]
|
S*BIO Appoints Joy Zhu Senior Vice President of Global Clinical Development
HSMN NewsFeed,
27 Oct 2006:
Biopharmaceuticals, Personnel
[S*BIO]
|
Royalty Pharma Announces Agreement Regarding the Purchase of the Rights to a Pre-Existing Royalty Interest in HUMIRA(R) From AstraZeneca and CAT
HSMN NewsFeed,
26 Oct 2006:
Biopharmaceuticals
[Royalty Pharma, Abbott, AstraZeneca, HUMIRA, adalimumab]
|
Former Amgen Manufacturing Executive Joins Insmed
HSMN NewsFeed,
25 Oct 2006:
Biopharmaceuticals, Personnel
[Insmed]
|
Amgen Completes Acquisition of Avidia
HSMN NewsFeed,
24 Oct 2006:
Biopharmaceuticals, Mergers & Acquisitions
[Amgen, Avidia, Avimer , interleukin 6]
|
U.S. Court Begins Discovery Phase in Patent Infringement Suit
HSMN NewsFeed,
20 Oct 2006:
Biopharmaceuticals, Litigation
[ Roche , Amgen, erythropoietin, continuous erythropoietin receptor activator]
|
U.S. District Court Denies Roche Motion to Dismiss Amgen Patent Infringement Lawsuit
HSMN NewsFeed,
20 Oct 2006:
Biopharmaceuticals, Litigation
[Amgen, Roche , peg-EPO, EPOGEN, Aranesp]
|
Fresenius Medical Care Announces New Sourcing and Supply Agreement with Amgen
HSMN NewsFeed,
19 Oct 2006:
Biopharmaceuticals
[Fresenius Medical Care AG, Amgen]
|
Geron Appoints Alan Colowick as President, Oncology
HSMN NewsFeed,
16 Oct 2006:
Biopharmaceuticals, Personnel
[Geron Corp]
|
Hana Biosciences Licenses Drug Candidate for the Prevention and Treatment of EGFR Inhibitor-Associated Skin Rash
HSMN NewsFeed,
16 Oct 2006:
Biopharmaceuticals, Oncology, Licensing
[Hana Biosciences, Menadione]
|
Amgen Receives Complete Response Letter for Extended Dosing of Aranesp(R) for Patients with Chronic Kidney Disease and Anemia
HSMN NewsFeed,
13 Oct 2006:
Biopharmaceuticals, FDA
[Amgen, Aranesp, darbepoetin alfa, kidney disease]
|
Array BioPharma Appoints April H. Teitelbaum, MD, MS, FACP Vice President of Clinical Development - Oncology
HSMN NewsFeed,
5 Oct 2006:
Biopharmaceuticals, Personnel
[Array BioPharma]
|
Dako Receives FDA Approval for Use of EGFR pharmDx(TM) With Vectibix(TM)
HSMN NewsFeed,
4 Oct 2006:
Diagnostics, FDA, Oncology
[Dako , EGFR pharmDx, Vectibix, panitumumab, Amgen, colorectal cancer]
|
Amgen to Acquire Avidia, a Privately Held Biopharmaceutical Company in the San Francisco Bay Area
HSMN NewsFeed,
29 Sep 2006:
Biopharmaceuticals, Mergers & Acquisitions
[Amgen, Avidia, Avimer]
|
FDA Approves Vectibix(TM) to Treat Patients with Metastatic Colorectal Cancer
HSMN NewsFeed,
27 Sep 2006:
Biopharmaceuticals, Oncology, FDA
[Amgen, Vectibix, panitumumab, EGFr , colorectal cancer, targeted therapy]
|
EPIX Pharmaceuticals Announces Top-line Results from Phase 3 Trial of PRX-00023 in Generalized Anxiety Disorder
HSMN NewsFeed,
21 Sep 2006:
Biopharmaceuticals
[EPIX Pharmaceuticals, PRX-00023]
|
Amgen Names Thomas Flanagan Senior Vice President and Chief Information Officer
HSMN NewsFeed,
20 Sep 2006:
Biopharmaceuticals, Personnel
[Amgen]
|
EPIX Announces Australian Approval of Vasovist(TM)
HSMN NewsFeed,
20 Sep 2006:
Biopharmaceuticals, Regulatory
[EPIX Pharmaceuticals, Vasovist, contrast agent, imaging]
|
Amgen Announces License Agreement with Yeda Research and Development Company Ltd.
HSMN NewsFeed,
19 Sep 2006:
Biopharmaceuticals, Oncology, Licensing
[Amgen, Yeda Research and Development]
|
Avera Pharmaceuticals Names Dinu Sen Chief Executive Officer
HSMN NewsFeed,
14 Sep 2006:
Biopharmaceuticals, Personnel
[Avera Pharmaceuticals]
|
Genmab Initiates HuMax-EGFr Pivotal Study In Refractory Head and Neck Cancer
HSMN NewsFeed,
14 Sep 2006:
Biopharmaceuticals, Oncology
[Genmab, HuMax, EGFr, zalutumumab, head and neck cancer]
|
ARIAD Announces Update Regarding NF-(kappa)B Patent Lawsuit with Amgen
HSMN NewsFeed,
12 Sep 2006:
Biopharmaceuticals, Litigation
[ARIAD Pharmaceuticals, Amgen, Enbrel, Kineret]
|
Amgen Launches Aranesp(R) (Darbepoetin Alfa) Prefilled SureClick(TM) Autoinjector for Treatment of Anemia Associated with Chemotherapy and Chronic Kidney Disease
HSMN NewsFeed,
7 Sep 2006:
Biopharmaceuticals
[Amgen, Aranesp, darbepoetin alfa, SureClick, autoinjector]
|
Abraxis Oncology Appoints Vice President Global Drug Development
HSMN NewsFeed,
6 Sep 2006:
Biopharmaceuticals, Oncology, Personnel
[Abraxis Oncology, Abraxis BioScience]
|
Idenix Pharmaceuticals, Inc. Announces Appointment of John F. Weidenbruch as Executive Vice President and General Counsel
HSMN NewsFeed,
5 Sep 2006:
Biopharmaceuticals, Personnel
[Idenix Pharmaceuticals]
|
EPIX Pharmaceuticals Receives Response from the FDA Regarding Appeal of Vasovist(TM) Approvable Letters
HSMN NewsFeed,
28 Aug 2006:
Biopharmaceuticals, FDA
[EPIX Pharmaceuticals, Vasovist]
|
Cephalon, Inc. Appoints Dr. Lesley Russell as Senior Vice President Worldwide Medical and Regulatory Operations
HSMN NewsFeed,
25 Aug 2006:
Biopharmaceuticals, Personnel
[ Cephalon]
|
EPIX and Predix Pharmaceuticals Complete Merger
HSMN NewsFeed,
16 Aug 2006:
Biopharmaceuticals, Mergers & Acquisitions
[EPIX Pharmaceuticals, Predix Pharmaceuticals]
|
Anesiva Bolsters Executive Team With Two Vice President Appointments
HSMN NewsFeed,
16 Aug 2006:
Biopharmaceuticals, Personnel
[Anesiva, Corgentech]
|
ZymoGenetics Files Lawsuit Against Bristol-Myers Squibb for Infringement of Fusion Protein Patents
HSMN NewsFeed,
14 Aug 2006:
Biopharmaceuticals, Litigation
[ZymoGenetics, Bristol-Myers Squibb]
|
Vasovist(TM) Recommended for Approval in Australia
HSMN NewsFeed,
14 Aug 2006:
Biopharmaceuticals, Radiology, Regulatory
[EPIX Pharmaceuticals, Vasovist, imaging agent]
|
Amgen Wins TKT Appeal
HSMN NewsFeed,
3 Aug 2006:
Biopharmaceuticals, Litigation
[Amgen, Transkaryotic Therapies, sanofi-aventis, erythropoietin]
|
Affymax Appoints Jeffrey H. Knapp as Chief Commercialization Officer
HSMN NewsFeed,
26 Jul 2006:
Biopharmaceuticals, Personnel
[Affymax]
|
Nuvelo Appoints H. Ward Wolff as Chief Financial Officer and Jill M. Pergande as Vice President, Human Resources
HSMN NewsFeed,
19 Jul 2006:
Biopharmaceuticals, Personnel
[Nuvelo]
|
Amgen Announces EVOLVE Trial(TM) To Investigate Impact of Sensipar(R)/Mimpara(R) (cinacalcet HCl) on Mortality and Cardiovascular Morbidity in Secondary Hyperparathyroidism Patients With Chronic Kidney Disease Receiving Dialysis
HSMN NewsFeed,
16 Jul 2006:
Biopharmaceuticals
[Amgen, chronic kidney disease, Sensipar/Mimpara, cinacalcet, EVOLVE trial]
|
ImmunoGen, Inc. Grants Biotest AG Rights to Use ImmunoGen TAP Technology to Develop Novel Anticancer Therapeutics
HSMN NewsFeed,
11 Jul 2006:
Biopharmaceuticals, Licensing
[ImmunoGen, Biotest AG, Tumor-Activated Prodrug]
|
Alexion Pharmaceuticals Appoints David L. Hallal Vice President U.S. Commercial Operations
HSMN NewsFeed,
6 Jul 2006:
Biopharmaceuticals, Personnel
[Alexion Pharmaceuticals]
|
SkinMedica Appoints Theodore Ebel Vice President of Corporate Development
HSMN NewsFeed,
5 Jul 2006:
Biopharmaceuticals, Personnel
[SkinMedica]
|
Amicus Therapeutics Adds Glenn P. Sblendorio to Board of Directors
HSMN NewsFeed,
5 Jul 2006:
Biopharmaceuticals, Personnel
[Amicus Therapeutics]
|
Nuvelo Expands Depth in Manufacturing and Development With Key Additions to Management Team
HSMN NewsFeed,
29 Jun 2006:
Biopharmaceuticals, Personnel
[Nuvelo]
|
Exelixis Appoints Experienced Biotechnology Executive as Chief Medical Officer
HSMN NewsFeed,
26 Jun 2006:
Biopharmaceuticals, Personnel
[Exelixis, Gisela M. Schwab]
|
BioAlliance Pharma Strengthens Operational Management Ahead of Loramyc(R) Launch
HSMN NewsFeed,
26 Jun 2006:
Biopharmaceuticals, Personnel
[BioAlliance Pharma]
|
VLST Corporation Raises $55 Million
HSMN NewsFeed,
16 Jun 2006:
Biopharmaceuticals, Venture Capital
[VLST]
|
OXiGENE Appoints Chief Medical Officer, Dr. Peter Harris
HSMN NewsFeed,
14 Jun 2006:
Biopharmaceuticals, Personnel
[OXiGENE]
|
FDA Grants Priority Review of Panitumumab for Treatment of Patients with Metastatic Colorectal Cancer
HSMN NewsFeed,
12 Jun 2006:
Biopharmaceuticals, Oncology, FDA
[Amgen, panitumumab, metastatic colorectal cancer]
|
Interim Data Suggest Potential Benefits of Aranesp(R) Dosed Every Three Weeks with Intravenous Iron for Chemotherapy-Induced Anemia
HSMN NewsFeed,
3 Jun 2006:
Biopharmaceuticals, Oncology
[Amgen, Aranesp, darbepoetin alfa]
|
Regeneron Receives Fast-Track Designation for the IL-1 Trap in CIAS1-Associated Periodic Syndromes (CAPS)
HSMN NewsFeed,
31 May 2006:
Biopharmaceuticals, FDA
[Regeneron Pharmaceuticals, IL-1 Trap, Interleukin-1]
|
Abraxis BioScience Appoints New Officers to Executive Management Team
HSMN NewsFeed,
25 May 2006:
Biopharmaceuticals, Personnel
[Abraxis BioScience]
|
Large Head-to-Head Study of Aranesp(R) Dosed Every Two Weeks versus Epoetin Alfa Dosed Weekly Published in the Journal of Clinical Oncology
HSMN NewsFeed,
18 May 2006:
Biopharmaceuticals, Oncology
[Amgen, Aranesp, darbepoetin alfa]
|
Renovis Names Donald R. Joseph as Senior Vice President, Corporate Development and General Counsel
HSMN NewsFeed,
17 May 2006:
Biopharmaceuticals, Personnel
[Renovis]
|
ConjuChem Announces New Executive Vice President, Research and Development
HSMN NewsFeed,
11 May 2006:
Biopharmaceuticals, Personnel
[ConjuChem]
|
ITC Accepts Amgen's Complaint to Investigate Roche's Importation of Peg-EPO
HSMN NewsFeed,
9 May 2006:
Biopharmaceuticals
[Amgen, Roche , peg-EPO]
|
ImmunoGen, Inc. to Develop Commercial-Scale Manufacturing Process for Trastuzumab-DM1 for Genentech
HSMN NewsFeed,
4 May 2006:
Biopharmaceuticals
[ImmunoGen, Genentech]
|
Jury Rules in Favor of ARIAD and Co-Plaintiffs in Lilly NF-(kappa)B Patent Infringement Lawsuit
HSMN NewsFeed,
4 May 2006:
Biopharmaceuticals, Litigation
[ARIAD Pharmaceuticals, Eli Lilly, NF-(kappa)B, Evista , Xigris]
|
ARIAD Announces Lawsuit Relating to NF-(kappa)B Patent
HSMN NewsFeed,
24 Apr 2006:
Biopharmaceuticals, Litigation
[ARIAD Pharmaceuticals, Amgen, Enbrel, Kineret]
|
Discovery Partners International and Infinity Pharmaceuticals Announce Merger Agreement
HSMN NewsFeed,
12 Apr 2006:
Biopharmaceuticals, Mergers & Acquisitions
[Discovery Partners International, Infinity Pharmaceuticals]
|
Amgen Files with ITC Against Roche's Importation of peg-EPO
HSMN NewsFeed,
11 Apr 2006:
Biopharmaceuticals
[Amgen, Roche, peg-EPO]
|
Genentech Announces Vice President Appointments in Commercial Operations and Product Development
HSMN NewsFeed,
10 Apr 2006:
Biopharmaceuticals, Personnel
[Genentech]
|
Randomized Phase 3 Trial Shows Panitumumab Significantly Improved Progression-Free Survival and Disease Control in Metastatic Colorectal Cancer Patients
HSMN NewsFeed,
3 Apr 2006:
Biopharmaceuticals, Oncology
[Amgen, panitumumab, colorectal cancer]
|
Amgen Completes Acquisition of Abgenix
HSMN NewsFeed,
3 Apr 2006:
Biopharmaceuticals. Mergers & Acquisitions
[Amgen, Abgenix]
|
Amgen and Abgenix Complete Biologics License Application for FDA Approval of Panitumumab
HSMN NewsFeed,
30 Mar 2006:
Biopharmaceuticals, Oncology, FDA
[Amgen, Abgenix, panitumumab, colorectal cancer]
|
David Parkinson, MD Joins Biogen Idec as Head of Oncology Research and Development
HSMN NewsFeed,
29 Mar 2006:
Biopharmaceuticals, Personnel
[Biogen Idec]
|
Threshold Announces Management Additions
HSMN NewsFeed,
28 Mar 2006:
Biopharmaceuticals, Personnel
[Threshold Pharmaceuticals]
|
FDA Approves Extended Dosing of Aranesp(R) to Treat Chemotherapy-Induced Anemia
HSMN NewsFeed,
27 Mar 2006:
Biopharmaceuticals, FDA
[Amgen, Aranesp, darbepoetin alfa]
|
Carol G. Gallagher, Pharm. D., to Join Anadys Pharmaceuticals as Vice President, Commercial Affairs
HSMN NewsFeed,
22 Mar 2006:
Biopharmaceuticals, Personnel
[Anadys Pharmaceuticals]
|
New Phase 2 Data Suggest Treatment of Anemia with Aranesp(R) (Darbepoetin Alfa) May Provide Clinical Benefits in Heart Failure Patients
HSMN NewsFeed,
13 Mar 2006:
Biopharmaceuticals, Cardiology
[Amgen, RED-HF, Aranesp, darbepoetin alfa, anemia]
|
Investigational Therapy Denosumab Increased Bone Mineral Density with Twice-Yearly Dosing
HSMN NewsFeed,
22 Feb 2006:
Biopharmaceuticals
[Amgen, denosumab, bone mineral density, FOSAMAX, Merck]
|
Kosan Expands Executive Management Team
HSMN NewsFeed,
22 Feb 2006:
Biopharmaceuticals, Personnel
[Kosan Biosciences]
|
IDM and GENESIS Pharma Sign an Exclusive Marketing Agreement for Junovan(TM) in South East Europe
HSMN NewsFeed,
21 Feb 2006:
Biopharmaceuticals, Licensing
[IDM Pharma, GENESIS Pharma, Junovan]
|
Keryx Biopharmaceuticals Names Ronald C. Renaud, Jr. as Chief Financial Officer
HSMN NewsFeed,
16 Feb 2006:
Biopharmaceuticals, Personnel
[Keryx Biopharmaceuticals]
|
Amgen and Genentech Sign License Agreements For Antibody Patents
HSMN NewsFeed,
26 Jan 2006:
Biopharmaceuticals, Licensing
[Amgen, Genentech]
|
Corgentech Announces Management Promotions
HSMN NewsFeed,
19 Jan 2006:
Biopharmaceuticals, Personnel
[Corgentech]
|
Human Genome Sciences Announces License Agreement With Amgen
HSMN NewsFeed,
9 Jan 2006:
Biopharmaceuticals, Licensing
[Human Genome Sciences, Amgen]
|
VLST Corporation and Accelerator Corporation Name Martin A. Simonetti President and Chief Executive Officer of VLST
HSMN NewsFeed,
6 Jan 2006:
Biopharmaceuticals, Personnel
[VLST Corporation, Accelerator Corporation]
|
ChemoCentryx Announces Key Senior Management Team Additions
HSMN NewsFeed,
5 Jan 2006:
Biopharmaceuticals, Personnel
[ChemoCentryx]
|
Metabasis Therapeutics, Inc. Announces Three Senior Management Additions to Development Team
HSMN NewsFeed,
5 Jan 2006:
Biopharmaceuticals, Personnel
[Metabasis Therapeutics]
|
Genmab's HuMax-EGFr Awarded Fast Track Status From FDA
HSMN NewsFeed,
3 Jan 2006:
Biopharmaceuticals, Oncology, FDA
[Genmab, HuMax-EGFr, head and neck cancer]
|
Valeant Pharmaceuticals Completes Acquisition of Hep-C Drug Infergen(R) From InterMune
HSMN NewsFeed,
3 Jan 2006:
Biopharmaceuticals, Acquisitions
[Valeant Pharmaceuticals, InterMune, Infergen, hepatitis C]
|
Genmab Appoints Annarie Lyles as Head of Business Development
HSMN NewsFeed,
3 Jan 2006:
Biopharmaceuticals, Personnel
[Genmab]
|
|
|
Public
Feeds 
Full text >>